Themis Bioscience is based in Vienna, Austria. It has raised $95M in total funding. Latest round: Series D.
Themis Bioscience is based in Vienna, Austria. Themis Bioscience has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in September 2019. The round record for Themis Bioscience runs through 2019; nothing later has been disclosed. Investors on record include Merck Sharp & Dohme (MSD), Farallon Capital, Hadean Ventures, Global Health Investment Fund, Adjuvant Capital, aws Gruenderfonds and 3 others. 9 distinct backers are named across the disclosed rounds.
Totals shown for Themis Bioscience aggregate every disclosed round on file. To see how that compares, browse the companies in Vienna and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026